Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma.
Schechter T, Perez-Albuerne E, Lin TF, Irwin MS, Essa M, Desai AV, Frangoul H, Yanik G, Dupuis LL, Jacobsohn D, Kletzel M, Ranalli M, Soni S, Seif AE, Grupp S, Dvorak CC. Schechter T, et al. Among authors: kletzel m. Bone Marrow Transplant. 2020 Mar;55(3):531-537. doi: 10.1038/s41409-018-0298-y. Epub 2018 Sep 4. Bone Marrow Transplant. 2020. PMID: 30181580
Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busulfan in children undergoing a reduced-intensity conditioning regimen with hematopoietic stem cell transplantation.
Kletzel M, Jacobsohn D, Duerst R. Kletzel M, et al. Biol Blood Marrow Transplant. 2006 Apr;12(4):472-9. doi: 10.1016/j.bbmt.2005.12.028. Biol Blood Marrow Transplant. 2006. PMID: 16545731 Free article. Clinical Trial.
A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1.
Seif AE, Naranjo A, Baker DL, Bunin NJ, Kletzel M, Kretschmar CS, Maris JM, McGrady PW, von Allmen D, Cohn SL, London WB, Park JR, Diller LR, Grupp SA. Seif AE, et al. Among authors: kletzel m. Bone Marrow Transplant. 2013 Jul;48(7):947-52. doi: 10.1038/bmt.2012.276. Epub 2013 Jan 21. Bone Marrow Transplant. 2013. PMID: 23334272 Free PMC article. Clinical Trial.
Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation.
Duncan CN, Brazauskas R, Huang J, Shaw BE, Majhail NS, Savani BN, Flowers MED, Battiwalla M, Beebe K, Dietz AC, Dvorak CC, Giller R, Jacobsohn DA, Kletzel M, Martin PL, Nemecek ER, Nuechterlein B, Talano JA, Pulsipher MA, Baker KS. Duncan CN, et al. Among authors: kletzel m. Bone Marrow Transplant. 2018 Oct;53(10):1278-1287. doi: 10.1038/s41409-018-0155-z. Epub 2018 Mar 26. Bone Marrow Transplant. 2018. PMID: 29581480 Free PMC article.
Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies.
Rossoff J, Jacobsohn D, Kwon S, Kletzel M, Duerst RE, Tse WT, Schneiderman J, Chaudhury S. Rossoff J, et al. Among authors: kletzel m. Pediatr Blood Cancer. 2021 Aug;68(8):e29087. doi: 10.1002/pbc.29087. Epub 2021 May 22. Pediatr Blood Cancer. 2021. PMID: 34022093
145 results